182 related articles for article (PubMed ID: 25286783)
1. Effects of anti-Müllerian hormone and follicle stimulating hormone levels on in vitro fertilization pregnancy rate.
Chen YP; Wu WH; Wu HM; Chen CK; Wang HS; Huang HY
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):313-6. PubMed ID: 25286783
[TBL] [Abstract][Full Text] [Related]
2. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
[TBL] [Abstract][Full Text] [Related]
3. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
4. Discordant anti-müllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?
Wang S; Zhang Y; Mensah V; Huber WJ; Huang YT; Alvero R
J Ovarian Res; 2018 Jul; 11(1):60. PubMed ID: 30012195
[TBL] [Abstract][Full Text] [Related]
5. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.
Sahmay S; Guralp O; Aydogan B; Cepni I; Oral E; Irez T
Gynecol Endocrinol; 2013 May; 29(5):440-3. PubMed ID: 23461296
[TBL] [Abstract][Full Text] [Related]
6. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of combined FSH and AMH observations in infertile women.
Gleicher N; Kim A; Kushnir V; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
J Clin Endocrinol Metab; 2013 May; 98(5):2136-45. PubMed ID: 23533225
[TBL] [Abstract][Full Text] [Related]
8. Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.
Barad DH; Weghofer A; Gleicher N
Fertil Steril; 2009 Apr; 91(4 Suppl):1553-5. PubMed ID: 19217095
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
10. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
11. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels.
Weghofer A; Dietrich W; Barad DH; Gleicher N
Hum Reprod; 2011 Jul; 26(7):1905-9. PubMed ID: 21531994
[TBL] [Abstract][Full Text] [Related]
12. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
[TBL] [Abstract][Full Text] [Related]
13. Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.
Sahmay S; Demirayak G; Guralp O; Ocal P; Senturk LM; Oral E; Irez T
J Assist Reprod Genet; 2012 Jul; 29(7):589-95. PubMed ID: 22492221
[TBL] [Abstract][Full Text] [Related]
14. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study.
Daney de Marcillac F; Pinton A; Guillaume A; Sagot P; Pirrello O; Rongieres C
J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):629-635. PubMed ID: 28843783
[TBL] [Abstract][Full Text] [Related]
15. Age effect on in vitro fertilization pregnancy mediated by anti-Mullerian hormone (AMH) and modified by follicle stimulating hormone (FSH).
Hsieh HC; Su JY; Wang S; Huang YT
BMC Pregnancy Childbirth; 2020 Apr; 20(1):209. PubMed ID: 32272911
[TBL] [Abstract][Full Text] [Related]
16. Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH.
Gleicher N; Kushnir VA; Sen A; Darmon SK; Weghofer A; Wu YG; Wang Q; Zhang L; Albertini DF; Barad DH
J Transl Med; 2016 Jun; 14(1):172. PubMed ID: 27286817
[TBL] [Abstract][Full Text] [Related]
17. [Predictive value of anti-Mullerian hormone levels in serum and follicle fluid for IVF-ET outcomes in patients with polycystic ovarian syndrome].
Chen X; Yin M; Ye D; He Y; Chen S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):546-9. PubMed ID: 23644117
[TBL] [Abstract][Full Text] [Related]
18. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels.
Singer T; Barad DH; Weghofer A; Gleicher N
Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223
[TBL] [Abstract][Full Text] [Related]
19. The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age.
Wang JG; Douglas NC; Nakhuda GS; Choi JM; Park SJ; Thornton MH; Guarnaccia MM; Sauer MV
Reprod Biomed Online; 2010 Dec; 21(6):757-61. PubMed ID: 21044868
[TBL] [Abstract][Full Text] [Related]
20. [Value of anti-Müllerian hormone and age in predicting pregnancy outcomes of in vitro fertilization and embryo transfer treatment].
Chen YH; Wang Q; Zhang YN; Xu XH; Lu J; Zhang SD; Zhang CL
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):239-244. PubMed ID: 31006189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
